Stocktoria
VERTEX PHARMACEUTICALS INC / MA VRTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1991-07-24
VERTEX PHARMACEUTICALS INC / MA statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 34.8% | -2.1% | 38.8% | 48.2% | 36.7% |
| Net margin | 32.9% | -4.9% | 36.7% | 37.2% | 30.9% |
| FCF margin | 26.6% | -7.2% | 33.8% | 44.0% | 31.8% |
| Return on assets | 15.4% | -2.4% | 15.9% | 18.3% | 17.4% |
| Return on equity | 21.2% | -3.3% | 20.6% | 23.9% | 23.2% |
| Current ratio | 2.90 | 2.69 | 3.99 | 4.83 | 4.46 |
| Revenue growth | 8.9% | 11.7% | 10.5% | 17.9% | 22.1% |
Source: SEC EDGAR filings · CIK 0000875320 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.